EF
GILD icon

Empowered Funds’s Gilead Sciences GILD Stock Holding History

Empowered Funds’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,151
Closed -$442K – 592
2022
Q4 		$442K Buy
+5,151
New +$408K 0.03% 366

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Empowered Funds's GILD Position: Q1 2026 in Review

Empowered Funds opened a new position in Gilead Sciences (GILD) in Q1 2026: 195,463 shares worth $27.2M. The stake represents 0.17% of the portfolio and ranks #108 among its holdings. This is a return to the name: Empowered Funds previously reported a position in GILD as recently as Q3 2025.

Empowered Funds first reported a position in GILD in Q1 2017 and has held it in 28 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Empowered Funds held 195,463 shares of Gilead Sciences worth $27.2M as of Q1 2026.
  • Gilead Sciences was a new Empowered Funds position in Q1 2026.
  • Gilead Sciences made up 0.17% of Empowered Funds's portfolio in Q1 2026, its #108 holding.
  • Empowered Funds first reported a position in Gilead Sciences in Q1 2017 and has held it in 28 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.